GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if the cancer is detected after the cancer cells have migrated, that number ...

Lymphovascular invasion is a pathologic feature commonly associated with aggressive renal cell carcinoma (RCC) and worse prognosis.

Submitted by Northwestern A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive ...

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new ...

One day, a dog named Scout might save your child’s life. It’s not a stretch. In fact, that possibility is fast becoming ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Metastatic breast cancer market is projected to grow significantly through 2035, driven by rising cases, treatment advances, and expanding R&D investments.

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Ankit Bharat, MD, can still remember Cornelia Tischmacher stopping their first telehealth conversation every few words to ...